Factors Influencing Thai University Students' Decisions to Take COVID-19 Vaccine Booster Doses: a Cross-sectional Survey

Overview

Journal Trop Med Health

Specialty Tropical Medicine

Date 2024 Apr 17

PMID 38632632

Authors

Weerakorn Thichumpa

Naphat Yimthin

Anawat Ratchatorn

Satoko Izumi

Wirichada Pan-Ngum

Affiliations

Soon will be listed here.

Abstract

Background: We aimed to describe the acceptance of COVID-19 vaccine booster doses and factors influencing this among Thai university students.

Methods: A cross-sectional survey was conducted between July and September 2022. All university students in Thailand were eligible to participate. We explored the acceptance rate of COVID-19 vaccine booster doses and regular vaccines (if available) among university students. Associations between factors influencing the acceptance of vaccination were analyzed by multiple logistic regression analysis.

Results: A total of 322 participants were surveyed (78.9% female, age 18 to 49 years (mean = 22.6, standard deviation = 5.47)). Most participants (85.7%) were undergraduate students (Bachelor level), and a proportion (84.8%) had a background in health sciences studies. The proportions who accepted booster doses and regular vaccines were 52.8% and 69.3%, respectively. Vaccine accessibility was found to be significantly associated with the acceptance of booster doses (adjusted odds ratio (AOR) = 2.77, 95% confidence interval (CI) = 1.10-6.97), while the availability of scientific evidence (AOR = 3.44, 95% CI = 1.21-9.77) was significantly associated with the acceptance of regular vaccines.

Conclusions: This study contributes to addressing the knowledge gap regarding acceptance of COVID-19 vaccine booster doses among university students in Thailand. Our findings revealed that vaccine accessibility and the availability of scientific evidence, as well as vaccination costs, influenced individuals' decisions around accepting vaccine booster doses. Further research should focus on the dynamics of vaccine acceptance to facilitate the development of targeted strategies and support vaccination policymaking in Thailand.

References

Dziedzic A, Issa J, Hussain S, Tanasiewicz M, Wojtyczka R, Kubina R . COVID-19 vaccine booster hesitancy (VBH) of healthcare professionals and students in Poland: Cross-sectional survey-based study. Front Public Health. 2022; 10:938067. PMC: 9359622. DOI: 10.3389/fpubh.2022.938067. View

Wu N, Joyal-Desmarais K, Ribeiro P, Marques Vieira A, Stojanovic J, Sanuade C . Long-term effectiveness of COVID-19 vaccines against infections, hospitalisations, and mortality in adults: findings from a rapid living systematic evidence synthesis and meta-analysis up to December, 2022. Lancet Respir Med. 2023; 11(5):439-452. PMC: 9917454. DOI: 10.1016/S2213-2600(23)00015-2. View

Akther T, Nur T . A model of factors influencing COVID-19 vaccine acceptance: A synthesis of the theory of reasoned action, conspiracy theory belief, awareness, perceived usefulness, and perceived ease of use. PLoS One. 2022; 17(1):e0261869. PMC: 8754289. DOI: 10.1371/journal.pone.0261869. View

Muangman S, Pimainog Y, Kunaratnpruk S, Kanchanaphum P . The Prevalence of COVID-19 Infection in Students and Staff at a Private University in Thailand by Rapid SARS-CoV-2 Antigen Detection Assay. J Environ Public Health. 2022; 2022:2350522. PMC: 8897746. DOI: 10.1155/2022/2350522. View

Nath Roy D, Azam M, Islam E . Multi-dimensional potential factors influencing COVID-19 vaccine booster acceptance and hesitancy among university academic community in Bangladesh: A cross-sectional comparative study. PLoS One. 2023; 18(4):e0281395. PMC: 10101431. DOI: 10.1371/journal.pone.0281395. View

Shitu K, Wolde M, Handebo S, Kassie A . Acceptance and willingness to pay for COVID-19 vaccine among school teachers in Gondar City, Northwest Ethiopia. Trop Med Health. 2021; 49(1):63. PMC: 8352142. DOI: 10.1186/s41182-021-00337-9. View

Sirikalyanpaiboon M, Ousirimaneechai K, Phannajit J, Pitisuttithum P, Jantarabenjakul W, Chaiteerakij R . COVID-19 vaccine acceptance, hesitancy, and determinants among physicians in a university-based teaching hospital in Thailand. BMC Infect Dis. 2021; 21(1):1174. PMC: 8607407. DOI: 10.1186/s12879-021-06863-5. View

Attia S, Mausbach K, Klugar M, Howaldt H, Riad A . Prevalence and Drivers of COVID-19 Vaccine Booster Hesitancy Among German University Students and Employees. Front Public Health. 2022; 10:846861. PMC: 9021373. DOI: 10.3389/fpubh.2022.846861. View

Argote Tironi P, Barham E, Zuckerman Daly S, Gerez J, Marshall J, Pocasangre O . Messages that increase COVID-19 vaccine acceptance: Evidence from online experiments in six Latin American countries. PLoS One. 2021; 16(10):e0259059. PMC: 8553119. DOI: 10.1371/journal.pone.0259059. View

10.

Nattino G, Pennell M, Lemeshow S . Assessing the goodness of fit of logistic regression models in large samples: A modification of the Hosmer-Lemeshow test. Biometrics. 2020; 76(2):549-560. DOI: 10.1111/biom.13249. View

11.

Noh Y, Kim J, Yoon D, Choe Y, Choe S, Jung J . Predictors of COVID-19 booster vaccine hesitancy among fully vaccinated adults in Korea: a nationwide cross-sectional survey. Epidemiol Health. 2022; 44:e2022061. PMC: 9754905. DOI: 10.4178/epih.e2022061. View

12.

Boon-Itt S, Rompho N, Jiarnkamolchurn S, Skunkan Y . Interaction between age and health conditions in the intention to be vaccinated against COVID-19 in Thailand. Hum Vaccin Immunother. 2021; 17(12):4816-4822. PMC: 8903902. DOI: 10.1080/21645515.2021.1979378. View

13.

Siewchaisakul P, Sarakarn P, Nanthanangkul S, Longkul J, Boonchieng W, Wungrath J . Role of literacy, fear and hesitancy on acceptance of COVID-19 vaccine among village health volunteers in Thailand. PLoS One. 2022; 17(6):e0270023. PMC: 9231694. DOI: 10.1371/journal.pone.0270023. View

14.

Ukwishaka J, Ndayishimiye Y, Destine E, Danwang C, Kirakoya-Samadoulougou F . Global prevalence of coronavirus disease 2019 reinfection: a systematic review and meta-analysis. BMC Public Health. 2023; 23(1):778. PMC: 10140730. DOI: 10.1186/s12889-023-15626-7. View

15.

Thunstrom L, Ashworth M, Finnoff D, Newbold S . Hesitancy Toward a COVID-19 Vaccine. Ecohealth. 2021; 18(1):44-60. PMC: 8175934. DOI: 10.1007/s10393-021-01524-0. View

16.

Sturgis P, Brunton-Smith I, Jackson J . Trust in science, social consensus and vaccine confidence. Nat Hum Behav. 2021; 5(11):1528-1534. DOI: 10.1038/s41562-021-01115-7. View

17.

Dar-Odeh N, Abu-Hammad O, Qasem F, Jambi S, Alhodhodi A, Othman A . Long-term adverse events of three COVID-19 vaccines as reported by vaccinated physicians and dentists, a study from Jordan and Saudi Arabia. Hum Vaccin Immunother. 2022; 18(1):2039017. PMC: 9009903. DOI: 10.1080/21645515.2022.2039017. View

18.

Kuehn M, LaMori J, DeMartino J, Mesa-Frias M, Doran J, Korrapati L . Assessing barriers to access and equity for COVID-19 vaccination in the US. BMC Public Health. 2022; 22(1):2263. PMC: 9719622. DOI: 10.1186/s12889-022-14636-1. View

19.

Rajatanavin N, Tuangratananon T, Suphanchaimat R, Tangcharoensathien V . Responding to the COVID-19 second wave in Thailand by diversifying and adapting lessons from the first wave. BMJ Glob Health. 2021; 6(7). PMC: 8295022. DOI: 10.1136/bmjgh-2021-006178. View

20.

Link-Gelles R, Levy M, Gaglani M, Irving S, Stockwell M, Dascomb K . Effectiveness of 2, 3, and 4 COVID-19 mRNA Vaccine Doses Among Immunocompetent Adults During Periods when SARS-CoV-2 Omicron BA.1 and BA.2/BA.2.12.1 Sublineages Predominated - VISION Network, 10 States, December 2021-June 2022. MMWR Morb Mortal Wkly Rep. 2022; 71(29):931-939. PMC: 9310634. DOI: 10.15585/mmwr.mm7129e1. View